Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.
Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns
Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Mediterranean Diet Associated with Improved Cardiometabolic Health in Youth, According to First Meta-Analysis of its Kind
Adherence to Mediterranean diet-based interventions was associated with reductions in BP, triglycerides, total cholesterol, and LDL-C, as well as increases in HDL-C among children and adolescents.
Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?
Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.
Immunotherapy to Delay, Treat Type 1 Diabetes Wins FDA Fast Track Designation
The antigen-specific immunotherapy preserves endogenous insulin production via intralymphatic injection of recombinant GAD65 protein, according to Diamyd Medical.
Weight Gain in Early Adult Life Linked to Adverse Cardiac Function, Structure in Older Age
Adiposity before age 60 to 64 years, beginning as early as age 20 years, was associated with adverse cardiac structure and function not explained by current BMI.